El 14 de noviembre, durante la Reunión Científica Anual virtual, la Dra. Luz Fonacier de Mineola NY, fue instalada como presidenta del ACAAI. La Dra. Fonacier es la cuarta mujer y la primera presidenta asiático-americana de la ACAAI.
Luz Fonacier, MD, of Mineola NY, was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the virtual ACAAI Annual Scientific Meeting on November 15.
Una presentación llevada a cabo en la Reunión científica anual del ACAAI de este año, revela las disparidades que existen para los niños negros e hispanos en cuanto a la Dermatitis Atópica (DA), comúnmente conocida como eccema.
A presentation at this year’s virtual ACAAI Annual Scientific Meeting reveals the disparities that exist for Black and Hispanic children when it comes to Atopic Dermatitis (AD), commonly known as eczema.
Un caso médicamente difícil presentado en la Reunión Científica Anual del ACAAI de este año, reveló que para un hombre con varias alergias cutáneas, el uso de una máscara desencadenó una dermatitis por contacto.
A medically challenging case presented at this year’s virtual ACAAI Annual Scientific Meeting revealed that for a man with several skin allergies, mask-wearing triggered his contact dermatitis.
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) .
November is National Healthy Skin Month, and it’s also the start of the holiday season when costs and spending can soar. Fortunately, dermatologists from the American Academy of Dermatology say there are several things people can do to reduce skin care costs while keeping their skin healthy and looking its best.
Botulinum toxin – best known by the brand name Botox – is a popular treatment to reduce facial lines and wrinkles. Over the years, plastic surgeons have explored alternative approaches to maximize effectiveness while minimizing side effects of botulinum toxin injection, including smaller doses and more-diluted concentrations.
Cosmetic surgery is not just another way of saying plastic surgery. Doctors who advertise themselves as certified by the American Board of Cosmetic Surgery (ABCS) don’t measure up to meet the criteria required for board-certified plastic surgeons.
Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.
Researchers used informatics to examine 5,000+ patient records and five years of data related to nursing skin assessments and hospital-acquired pressure injuries. The results underscore the importance of treating and monitoring irritated skin early and eliminating the cause as an important step to prevent pressure injuries.
Analysis of the largest registry of COVID-19 patients with dermatological symptoms has revealed a subset of patients, called ‘long-haulers’ or ‘long COVID’, who experience prolonged symptoms (lasting >60 days) on their skin.
The American Academy of Dermatology (AAD) named board-certified dermatologist Jennifer Tan, MD, FAAD, a Patient Care Hero for making critical skin care and hygiene items easily accessible to individuals experiencing homelessness during the COVID-19 pandemic.
The American Academy of Dermatology named board-certified dermatologist Brittany Smirnov, DO, FAAD, a Patient Care Hero for her role in diagnosing and treating a patient with stage IV metastatic lung cancer.
The American Academy of Dermatology named board-certified dermatologist Cyndi Yag-Howard, MD, FAAD, a Patient Care Hero for her work treating veterans with serious service-related skin conditions.
The nation faces physician shortages in primary care and other specialties, including a projected inadequate supply of dermatologists to meet the demand for service. This innovative program will help to address these gaps and will equip advanced-practice nurses with the tools required to provide high-quality, holistic care for their patients with dermatological conditions.
Kristen M. Kelly, MD, has been appointed chair for the University of California, Irvine School of Medicine Department of Dermatology, effective September 6, 2020.
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
Radiation therapy plays an important role in treating cancer. However, it can also produce some uncomfortable or even painful side effects on the skin, such as itchiness, redness, blistering and peeling. Without taking steps to minimize these side effects, dermatologists from the American Academy of Dermatology say radiation therapy can greatly impact patients’ quality of life and threaten their ability to continue treatment.
UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies.
New research finds that tattooed skin does not sweat as much as non-inked areas of the body, which may have implications for the body’s ability to cool in people with extensive tattooing.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States.
Dermatology researchers at Henry Ford Health System, in collaboration with a team at the University of Michigan, have demonstrated that certain N95 respirators tainted with COVID-19 can be effectively and safely decontaminated for reuse using ultraviolet-C light (UV-C), a method commonly utilized for treating rare skin diseases.
Researchers say the outside and inside of the facemasks were decontaminated in a prototype phototherapy unit that dispenses a UV-C dosing level high enough to effectively kill the virus in less than two minutes while still preserving the facemask’s breathability, fit and overall integrity.
The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.
The American Academy of Dermatology has named board-certified dermatologist Esther Freeman, MD, PhD, DTM&H, FAAD, a Patient Care Hero for developing an international registry that tracks the many ways COVID-19 manifests itself through the skin.
Commercials from pharmaceutical companies advertising medication to treat psoriasis and eczema lack people from racial and ethnic minorities, according to research from the Perelman School of Medicine at the University of Pennsylvania.
A new article published online in the Journal of the American Academy of Dermatology reveals just how common these illicit products are on popular e-commerce sites, increasing the public’s risk for severe and potentially long-term complications, including blindness, disfiguration, and stroke.
Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology. Most of these patients are not at any greater risk for COVID-19 than the general population, despite their weakened immune system.
UCLA researchers shed light on how interferon-gamma (IFN-y) guides the treatment response in people with advanced melanoma who are treated with one of the leading immunotherapies — immune checkpoint blockade.
Acne affects up to 50 million Americans. For people with skin of color, acne is often accompanied by dark spots or patches called hyperpigmentation. Dermatologists from the American Academy of Dermatology say there are plenty of things people with skin of color can do at home to help clear their acne.
Researchers at the George Washington University have found that the hair loss drug spironolactone is not associated with increased risk of female breast cancer recurrence and may be safe to treat female pattern hair loss in breast cancer survivors. Their findings are published in the Journal of the American Academy of Dermatology.
Because of the COVID-19 pandemic, masks have become the new normal. While wearing a mask in public is crucial, it can take a toll on your skin. The good news is there are several ways to prevent and treat acne and irritation caused by frequent face masking usage, also known as "maskne."
In a new article published in the Journal of Investigative Dermatology, Moffitt researchers identify erythropoietin-producing hepatocellular receptor A2 (EphA2) as a driver of metastasis and BRAF-MEK inhibitor resistance in melanoma.
As the coronavirus continues to spread throughout the country, many people may find themselves spending more time outdoors for a much-needed change of scenery. While gardening, hiking in the woods and swimming can provide relief amid continuous social distancing measures, dermatologists from the American Academy of Dermatology say the increased exposure to things like sunlight, insects and poisonous plants can cause some itchy and painful rashes. Fortunately, there are a few simple steps people can take to avoid unwanted rashes and other skin issues while still enjoying the outdoors.
Before lathering on the sunscreen and heading outdoors, it's important to know the signs of heat-related injuries and how to stay cool when the temperatures soar.
If you are noticing red, irritated skin or small pimples under your face mask, you are far from alone. Allison Truong, MD, a board-certified dermatologist with Cedars-Sinai Medical Group, says she is now seeing many patients complaining of what's commonly being called "maskne," or mask-acne.
With so many sunscreens out there, how do you know which one is effective—and safe—for your child? Dr. Minnelly Lu, pediatric dermatologist at Children's Hospital Los Angeles, shares the latest advice.
A consensus statement published today in JAMA Dermatology by a group of melanoma researchers evaluates the use of prognostic genetic expression profiling within clinical treatment of patients with melanoma. The group cautioned against routine use of currently-available genetic expression profiling tests for patients with cutaneous melanoma.
The American Academy of Dermatology (AAD) has named board-certified dermatologists Hon Pak, MD, FAAD, MBA, and Darryl Hodson, MD, FAAD, as Patient Care Heroes for their work launching the country’s first robust teledermatology project two decades ago.
Mount Sinai researchers have pinpointed a single gene biomarker, nitride oxide synthase 2 (NOS2) that can distinguish atopic dermatitis (AD) and psoriasis with 100 percent accuracy using adhesive tape strips, a non-invasive alternative to skin biopsy. The research will be published online today in the Journal of Allergy and Clinical Immunology.
While the majority of parents recognize the importance of sunscreen, they may not always use best practices to protect children from getting burned, a new national poll suggests.
A UCLA-led study has found that dermatopathologists, who specialize in diagnosing skin diseases at the microscopic level, are motivated both by patient safety concerns and by malpractice fears — often simultaneously — when ordering multiple tests and obtaining second opinions, with a higher proportion of these doctors reporting patient safety as a concern.
When ordering additional microscopic tests for patients, 90% of the dermatopathologists surveyed cited patient safety as a concern and 71% of them reported malpractice fears. Similarly, when obtaining second reviews from a consulting pathologist or recommending additional surgical sampling, 91% cited safety concerns and 78% malpractice concerns.
A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase Clinical Trials and Chief of Melanoma at Roswell Park Comprehensive Cancer Center and published today in the journal JAMA Oncology provides new insights into an important question: whether BRAF V600E/K mutation status or previous BRAF inhibitor (BRAFi) therapy with or without a MEK inhibitor (MEKi) affects response to pembrolizumab (brand name Keytruda) in patients with advanced melanoma.